Harvard Psychopharmacology
A Master Class
Advanced Psychopharmacology · Novel Therapeutics · Complex Clinical Scenarios
A comprehensive advanced educational program designed for prescribing clinicians seeking cutting-edge knowledge in psychiatric treatment.
VIDEO LECTURES
VTT SUBTITLES
PDF FILES
TOTAL SIZE
📚 Course Information
📅 Date: March 20–21, 2026
🎥 Videos: 19 Video Lectures
💬 Subtitles: 19 VTT Files
📄 Documents: 17 PDF Files
💾 Total Size: 6.76 GB
🔬 Course Overview
Harvard Psychopharmacology A Master Class is a comprehensive, advanced educational program designed for prescribing clinicians seeking cutting-edge knowledge in psychiatric treatment.
Held on March 20–21, 2026, this course delves into the neurobiology of mental illness, novel therapeutics, and complex clinical scenarios, providing evidence-based strategies for managing refractory depression, bipolar disorder, schizophrenia, and substance use disorders across diverse patient populations.
🎯 Learning Objectives
After completing this course, participants will be able to:
Understand the underlying neurobiology of psychiatric disorders to inform targeted psychopharmacological interventions.
Evaluate and implement advanced therapeutic strategies for difficult-to-treat conditions, including refractory depression and complex bipolar disorder.
Assess emerging treatments, such as neuromodulation approaches, psychedelics for PTSD, and the role of Apps/AI in psychiatric care.
Tailor psychopharmacologic treatments for specific populations, including geriatric, pediatric, perinatal, and substance use disorder patients.
👥 Target Audience
This master class is best for clinicians seeking key updates on advanced psychopharmacology and novel therapeutics.
📖 Topics Covered
📦 Complete Digital Package
VIDEOS
VTT SUBTITLE FILES
PDF FILES
TOTAL SIZE
Advanced Psychopharmacology for Prescribing Clinicians
Explore the neurobiology of psychiatric disorders, advanced treatment strategies, novel therapeutics, neuromodulation, psychedelics, Apps/AI, and psychopharmacologic approaches across diverse patient populations.













Reviews
There are no reviews yet.